Loading clinical trials...

A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingPhase 2NCT07375524

A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome

This is a multicenter, randomized, double-blind, placebo-controlled Phase II study designed to evaluate the efficacy and safety of ESG206 in participants with primary Sjögren's syndrome.

Lead sponsor: Shanghai Escugen Biotechnology Co., Ltd•21 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Qing Zhou, PhD

CONTACT

86 21 5855 6098 [email protected]

Related studies

RECRUITINGPhase 2

A Study of RSLV-132 in Females With Sjögren's Disease

NCT06440525 · Primary Sjögren Syndrome

RECRUITING

Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine

NCT06528197 · Primary Sjögren Syndrome

COMPLETED

Eye Dryness Evaluation in Primary Sjögren's Syndrome

NCT03614299 · Primary Sjögren Syndrome

COMPLETEDPhase 1

Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome

NCT04093531 · Primary Sjögren Syndrome

UNKNOWNPhase 1/2

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

NCT06049368 · Primary Sjögren Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 3, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhasePHASE2

Enrollment40

Start dateMar 2026

Last updatedFeb 3, 2026

Condition

Primary Sjögren Syndrome

Locations shown

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality

Peking University Shougang Hospital

Beijing, Beijing Municipality

The First Affiliated Hospital of Xiamen University

Xiamen, Fujian

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 3, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions